Drug:
Reaction: ASTHENIA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940102 |
EU |
52 | 1 |
Intestinal obstruction, General physical health deterioration, Asthenia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 2 | 26940216 |
US |
61 | 2 |
Asthenia, |
||||
BOTULINUM TOXIN TYPE A, |
||||
| 3 | 26940348 |
US |
31 | 1 |
Asthenia, Diarrhoea, Nausea, |
||||
OMAVELOXOLONE, |
||||
| 4 | 26940385 |
US |
2 | |
Irritable bowel syndrome, Asthenia, Nausea, Hypotension, Bone pain, Drug dose omission by device, Device issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 5 | 26940402 |
US |
70 | 2 |
Decreased appetite, Asthenia, |
||||
INAVOLISIB, PALBOCICLIB, |
||||
| 6 | 26940533 |
US |
1 | |
Dizziness, Asthenia, Headache, Bone pain, Chest pain, Sleep disorder, Pain in extremity, |
||||
ABALOPARATIDE, |
||||
| 7 | 26940575 |
CA |
49 | 2 |
Angina pectoris, Abdominal discomfort, Asthenia, Cough, Decreased appetite, Dehydration, Dyspnoea exertional, Gastrointestinal disorder, General physical health deterioration, Inflammation, Influenza like illness, Presyncope, Productive cough, Abdominal pain, Abdominal pain upper, Constipation, Diarrhoea, Fatigue, Headache, Nasopharyngitis, Nausea, Oral fungal infection, Upper respiratory tract infection, Viral infection, Condition aggravated, Pain, Rhinorrhoea, Therapeutic product effect delayed, Therapeutic response shortened, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 8 | 26940595 |
US |
2 | |
Hypotension, Increased need for sleep, Balance disorder, Asthenia, Fatigue, Headache, Nausea, Vertigo, Dizziness, Pain in extremity, |
||||
ABALOPARATIDE, |
||||
| 9 | 26940611 |
US |
58 | 2 |
Tension headache, Pain, Fatigue, Asthenia, |
||||
ABALOPARATIDE, BELIMUMAB, OMALIZUMAB, SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN CALCIUM, HYDROXYCHLOROQUINE SULFATE, PREGABALIN, RAMIPRIL, CLOPIDOGREL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PREDNISONE, ERGOCALCIFEROL, |
||||
| 10 | 26940658 |
US |
2 | |
Mental disorder, Physical deconditioning, Poor quality sleep, Asthenia, Fatigue, Headache, |
||||
ABALOPARATIDE, |
||||
| 11 | 26940680 |
US |
64 | 2 |
Vomiting, Palpitations, Tachycardia, Dyspnoea, Asthenia, Constipation, Blood calcium increased, |
||||
ABALOPARATIDE, MAGNESIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CLONAZEPAM, GABAPENTIN, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, TIZANIDINE, |
||||
| 12 | 26940749 |
1 | ||
Weight increased, Asthenia, |
||||
REVUMENIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACYCLOVIR, AMOXICILLIN, SACUBITRIL AND VALSARTAN, EMPAGLIFLOZIN, FUROSEMIDE, ATORVASTATIN CALCIUM, MAGNESIUM, POLYETHYLENE GLYCOL 3350, NITROGLYCERIN, POSACONAZOLE, SENNOSIDES, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, ASCORBIC ACID, ERGOCALCIFEROL, |
||||
| 13 | 26940809 |
US |
2 | |
Abdominal discomfort, Constipation, Palpitations, Fatigue, Asthenia, Cardiac disorder, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUOXETINE HYDROCHLORIDE, GABAPENTIN, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM, MELATONIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, TIOTROPIUM BROMIDE, ERGOCALCIFEROL, |
||||
| 14 | 26940889 |
CN |
33 | 1 |
Neutrophil count decreased, Chest discomfort, Asthenia, Nausea, Vomiting, White blood cell count decreased, Haemoglobin decreased, Decreased appetite, Off label use, |
||||
GEMCITABINE HYDROCHLORIDE, PEGASPARGASE, OXALIPLATIN, |
||||
| 15 | 26940917 |
US |
61 | 1 |
Glomerular filtration rate decreased, Nausea, Eructation, Vomiting, Fatigue, Diarrhoea, Headache, Blood corticotrophin increased, Lethargy, Asthenia, Cortisol increased, |
||||
LEVOKETOCONAZOLE, |
||||
| 16 | 26940947 |
US |
1 | |
Mobility decreased, Gait disturbance, Feeling abnormal, Blood parathyroid hormone decreased, Pain, Asthenia, Nausea, |
||||
ABALOPARATIDE, |
||||
| 17 | 26940982 |
US |
75 | 2 |
Depressed mood, Somnolence, Muscular weakness, Presyncope, Hypotension, Nervousness, Dizziness, Nausea, Back pain, Malaise, Headache, Asthenia, Fatigue, Feeling abnormal, |
||||
ABALOPARATIDE, LORAZEPAM, |
||||
| 18 | 26941014 |
US |
2 | |
Adverse drug reaction, Depression, Brain fog, Palpitations, Fatigue, Asthenia, Arthralgia, Pain in extremity, |
||||
ABALOPARATIDE, |
||||
| 19 | 26941100 |
US |
2 | |
Blood potassium increased, Dizziness, Asthenia, |
||||
ABALOPARATIDE, |
||||
| 20 | 26941108 |
US |
75 | 2 |
Illness, Depressed mood, Fear, Blood pressure abnormal, Feeling abnormal, Asthenia, |
||||
ABALOPARATIDE, LORAZEPAM, |
||||
| 21 | 26941194 |
MX |
61 | |
General physical condition abnormal, Early satiety, Dizziness, Asthenia, Product use issue, Product use in unapproved indication, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, LIRAGLUTIDE, ORAL SEMAGLUTIDE, SIROLIMUS, PREDNISONE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 22 | 26941349 |
EU |
55 | 2 |
Rash, Pain, Cognitive disorder, Apathy, Asthenia, Decreased appetite, |
||||
OLANZAPINE, SERTRALINE HYDROCHLORIDE, |
||||
| 23 | 26941480 |
US |
2 | |
Tongue blistering, Frustration tolerance decreased, Fatigue, Asthenia, |
||||
ABALOPARATIDE, |
||||
| 24 | 26941494 |
US |
2 | |
Blood pressure decreased, Fatigue, Asthenia, Sinus headache, Illness, Vomiting, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ALBUTEROL SULFATE, ALBUTEROL, FISH OIL, FLUTICASONE PROPIONATE, FLUOCINOLONE ACETONIDE, |
||||
| 25 | 26941503 |
US |
65 | 1 |
Suicidal ideation, Depression, Anxiety, Agitation, Restlessness, Asthenia, Panic attack, Insomnia, Aggression, Anger, Mood altered, Abnormal behaviour, Pain, Joint swelling, Fatigue, Confusional state, Amnesia, Somnolence, Headache, Gait disturbance, Coordination abnormal, Tinnitus, Increased appetite, Weight increased, Abdominal pain upper, Fall, Chills, Condition aggravated, Rapid eye movement sleep behaviour disorder, |
||||
DIVALPROEX SODIUM, DIVALPROEX SODIUM, |
||||
| 26 | 26941672 |
US |
63 | 2 |
Emotional disorder, Presyncope, Dyspnoea, Asthenia, Diarrhoea, Fatigue, Headache, Decreased appetite, Perioral dermatitis, Rash, |
||||
VANDETANIB, VENLAFAXINE HYDROCHLORIDE, |
||||
| 27 | 26941705 |
EU |
60 | 1 |
Asthenia, Creatine kinase increased, Myalgia, Contraindicated product administered, |
||||
| 28 | 26941823 |
US |
2 | |
Muscle twitching, Somnolence, Dizziness postural, Nocturia, Orthostatic hypertension, Depressed mood, Depression, Amnesia, Pollakiuria, Mood altered, Decreased appetite, Fatigue, Palpitations, Heart rate increased, Dizziness, Diarrhoea, Insomnia, Asthenia, Arthralgia, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 29 | 26941884 |
CA |
43 | 2 |
Breast cancer stage II, Asthenia, Dislocation of vertebra, Arthralgia, Gait inability, Malaise, Fluid retention, Rheumatoid factor positive, Urticaria, Joint swelling, Synovitis, Asthma, Hand deformity, Mobility decreased, Decreased appetite, Systemic lupus erythematosus, Wound, Rheumatoid arthritis, Lower limb fracture, Injury, Drug hypersensitivity, Road traffic accident, Musculoskeletal pain, Pemphigus, Blood cholesterol increased, Sciatica, Drug intolerance, Liver disorder, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SECUKINUMAB, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM, OXYCODONE, OXYCODONE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 30 | 26941928 |
US |
62 | 2 |
Asthenia, Weight decreased, Dehydration, Diarrhoea, Haematuria, Depressed mood, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 31 | 26941960 |
US |
2 | |
Decreased appetite, Lethargy, Asthenia, Nausea, |
||||
TIRZEPATIDE, ATENOLOL, LOSARTAN, |
||||
| 32 | 26941990 |
US |
1 | |
Fall, Decreased appetite, Asthenia, Ill-defined disorder, |
||||
SOTORASIB, |
||||
| 33 | 26942046 |
US |
1 | |
Asthenia, Condition aggravated, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 34 | 26942065 |
US |
74 | 1 |
Generalised tonic-clonic seizure, On and off phenomenon, Gait disturbance, Illness, Condition aggravated, Therapeutic response shortened, Urinary tract infection, Asthenia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 35 | 26942289 |
81 | 1 | |
Pruritus, Lacrimation increased, Sneezing, Cough, Asthenia, Somnolence, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 36 | 26942322 |
US |
||
Headache, Fall, Asthenia, Humerus fracture, |
||||
NUSINERSEN, |
||||
| 37 | 26942324 |
EU |
42 | 2 |
Respiratory distress, Peripheral swelling, Dizziness, Chills, Mitochondrial toxicity, Asthenia, Sleep disorder, Nervous system disorder, Memory impairment, Headache, Head discomfort, Ligament sprain, Joint noise, Myosclerosis, Vth nerve injury, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 38 | 26942424 |
US |
63 | 2 |
Pneumonia, Asthenia, Abdominal discomfort, Diarrhoea, Nausea, Product use in unapproved indication, |
||||
RILZABRUTINIB, FOLIC ACID, |
||||
| 39 | 26942475 |
EU |
75 | 2 |
Anal haemorrhage, Dyspnoea, Asthenia, Haemoglobin decreased, |
||||
CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, KETOPROFEN, |
||||
| 40 | 26942576 |
US |
62 | 2 |
Illness, Cardiac disorder, Asthenia, |
||||
TIRZEPATIDE, |
||||
| 41 | 26942621 |
KR |
||
Fatigue, Hypophagia, Asthenia, Tremor, Suspected off label use, |
||||
RITUXIMAB, ZANUBRUTINIB, |
||||
| 42 | 26943015 |
31 | 2 | |
Medication error, Hypophosphataemia, Restlessness, Abdominal distension, Asthenia, Nausea, |
||||
BISOPROLOL FUMARATE, MELATONIN, RIZATRIPTAN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, VIBEGRON, |
||||
| 43 | 26943112 |
CA |
44 | 2 |
Breast cancer stage III, Folliculitis, Sciatica, Hypoaesthesia, Memory impairment, Dyspepsia, Taste disorder, Crohn^s disease, Bone erosion, Gait inability, Gastrooesophageal reflux disease, Pneumonia, Decreased appetite, Insomnia, Disability, Confusional state, Grip strength decreased, Sleep disorder due to a general medical condition, Product use in unapproved indication, Blister, Adjustment disorder with depressed mood, Dislocation of vertebra, Hypercholesterolaemia, Lip dry, Blepharospasm, Systemic lupus erythematosus, Therapeutic product effect decreased, Anxiety, Delirium, Impaired healing, Infusion site reaction, Malaise, Bursitis, Facet joint syndrome, Lower respiratory tract infection, Dyspnoea, Drug intolerance, Prescribed overdose, Helicobacter infection, Dizziness, Sleep disorder, Rash, Glossodynia, C-reactive protein increased, Ulcer haemorrhage, Incorrect route of product administration, Therapeutic product effect incomplete, Maternal exposure during pregnancy, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Respiratory disorder, Psoriatic arthropathy, Urticaria, Depression, Contusion, Hepatic cirrhosis, Product quality issue, Hypersensitivity, Blood cholesterol increased, Drug hypersensitivity, Sinusitis, Exostosis, Discomfort, Deep vein thrombosis postoperative, Intentional product use issue, Condition aggravated, Diarrhoea, Hand deformity, Gait disturbance, Lower limb fracture, X-ray abnormal, Pericarditis, Stomatitis, Back injury, Duodenal ulcer perforation, Lupus-like syndrome, Ear pain, Ill-defined disorder, Alopecia, Fatigue, Synovitis, Type 2 diabetes mellitus, Prescribed underdose, Exposure during pregnancy, Rheumatoid factor positive, Product use issue, Epilepsy, Rheumatoid arthritis, Gastrointestinal disorder, Swollen joint count increased, Red blood cell sedimentation rate increased, Treatment failure, Irritable bowel syndrome, Contraindicated product administered, Swelling, Hypertension, Breast cancer stage II, Laryngitis, Drug ineffective, Pyrexia, Asthenia, Headache, Medication error, General physical health deterioration, Asthma, Therapy non-responder, Hepatic enzyme increased, Chest pain, Rheumatic fever, Drug tolerance, Fibromyalgia, Dry mouth, Peripheral swelling, Infusion related reaction, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, INFLIXIMAB, ABATACEPT, OXYCODONE, OXYCODONE, CELECOXIB, CELECOXIB, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, SECUKINUMAB, MEPOLIZUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CELECOXIB, CELECOXIB, RAMIPRIL, RAMIPRIL, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, |
||||
| 44 | 26943218 |
US |
50 | 2 |
Thirst, Overdose, Fatigue, Drug ineffective, Injection site irritation, Injection site mass, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 45 | 26943235 |
55 | 1 | |
Bradycardia, Hypotension, Pyrexia, Lung infiltration, Respiratory failure, Shock, Pulmonary embolism, Dyspnoea, Syncope, Anaemia, Asthenia, Cardio-respiratory arrest, Aspiration, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 46 | 26943238 |
US |
83 | 1 |
Back pain, Asthenia, Product dose omission issue, |
||||
TUCATINIB, |
||||
| 47 | 26943494 |
CN |
59 | 2 |
Myelosuppression, Asthenia, |
||||
TRASTUZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 48 | 26943497 |
81 | 2 | |
Colitis, Gastrointestinal disorder, Lung disorder, Asthenia, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 49 | 26943881 |
EU |
64 | 2 |
Epstein-Barr virus infection reactivation, Hyperglycaemia, Asthenia, Weight decreased, Odynophagia, Erythema, Atrophic glossitis, Pruritus, Rash maculo-papular, |
||||
PALBOCICLIB, INAVOLISIB, FULVESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 50 | 26943947 |
EU |
2 | |
Rectal haemorrhage, Gastrointestinal obstruction, Thrombocytopenia, Mitral valve incompetence, Asthenia, Nausea, Constipation, Hyperchlorhydria, Frequent bowel movements, Infection, Back pain, Haemorrhoids, Urticaria, Dyspnoea exertional, Sacral pain, Left ventricular dysfunction, Anorectal discomfort, Anal fissure, Pruritus, |
||||
BEVACIZUMAB, |
||||
| 51 | 26943990 |
US |
70 | 1 |
Asthenia, Fatigue, Dyspnoea, |
||||
RISDIPLAM, |
||||
| 52 | 26944085 |
US |
80 | 2 |
Somnolence, Vomiting, Diarrhoea, Asthenia, Nausea, Dizziness, |
||||
ABALOPARATIDE, AMLODIPINE, PANTOPRAZOLE, FEXOFENADINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, ALIROCUMAB, NITROGLYCERIN, EMPAGLIFLOZIN, NAPROXEN, NAPROXEN SODIUM, FENOFIBRATE, DONEPEZIL HYDROCHLORIDE, |
||||
| 53 | 26944092 |
EU |
74 | 2 |
Syncope, Pyelonephritis, Suprapubic pain, Pyrexia, Pain, Chills, Bacteraemia, Alopecia, Anxiety, Diarrhoea, COVID-19, Pyrexia, Malaise, Limb discomfort, Decreased appetite, Dysgeusia, Lung opacity, Haemoglobin decreased, Red blood cell count decreased, Haematocrit decreased, Mean cell volume increased, Mean cell haemoglobin increased, White blood cell count decreased, Glomerular filtration rate decreased, Alanine aminotransferase decreased, Blood urea increased, Blood creatinine increased, Peripheral swelling, Pain in extremity, Bladder discomfort, Dysuria, Dizziness, Influenza, Hypotension, Depressed mood, Breast mass, Affect lability, Tearfulness, Bone scan abnormal, Asthenia, Pain in jaw, Decreased immune responsiveness, Laboratory test abnormal, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 54 | 26944149 |
US |
78 | 2 |
Asthenia, |
||||
DUPILUMAB, |
||||
| 55 | 26944250 |
57 | 1 | |
Myelosuppression, Asthenia, Pyrexia, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 56 | 26944373 |
US |
53 | 2 |
Taste disorder, Diarrhoea, Abdominal discomfort, Asthenia, |
||||
| 57 | 26944389 |
US |
69 | 1 |
Fatigue, Asthenia, Social avoidant behaviour, |
||||
| 58 | 26944395 |
IN |
1 | |
Hypotension, Asthenia, |
||||
DURVALUMAB, |
||||
| 59 | 26944566 |
US |
71 | 2 |
Hypersensitivity, Decreased appetite, Cough, Primary cough headache, Hypoaesthesia, Sinus disorder, Fatigue, Asthenia, |
||||
ENASIDENIB MESYLATE, |
||||
| 60 | 26944629 |
US |
88 | 1 |
Inadequate analgesia, Asthenia, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 61 | 26944709 |
US |
1 | |
Asthenia, Feeling abnormal, Cough, Nausea, |
||||
SPARSENTAN, |
||||
| 62 | 26944721 |
EU |
86 | 2 |
Altered state of consciousness, Dehydration, Hypernatraemia, Asthenia, |
||||
EMPAGLIFLOZIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TORSEMIDE, PERINDOPRIL ERBUMINE, |
||||
| 63 | 26944744 |
US |
70 | 2 |
Illness, Chills, Feeling cold, Feeding disorder, Hot flush, Nausea, Asthenia, Back pain, Pain, Incorrect dose administered, |
||||
ABALOPARATIDE, |
||||
| 64 | 26944756 |
EU |
69 | 1 |
Haemoptysis, Asthenia, Neutropenia, Thrombocytopenia, Acute respiratory failure, Hypoxic-ischaemic encephalopathy, |
||||
PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, COLCHICINE, |
||||
| 65 | 26944824 |
US |
2 | |
Blood urine present, Gastrooesophageal reflux disease, Balance disorder, Polyuria, Musculoskeletal discomfort, Blood pressure increased, Injection site pain, Injection site erythema, Injection site swelling, Injection site reaction, Nausea, Fatigue, Vertigo, Asthenia, Renal disorder, Blood glucose increased, Product dose omission issue, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, VALSARTAN, VALSARTAN ORAL, HYOSCYAMINE SULFATE, MAGNESIUM, FLUTICASONE PROPIONATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TAMSULOSIN HYDROCHLORIDE, PEPPERMINT OIL, |
||||
| 66 | 26944845 |
US |
60 | 2 |
Aortic arteriosclerosis, Blood cholesterol abnormal, Low density lipoprotein abnormal, Lipoprotein (a) abnormal, Fatigue, Abnormal dreams, Asthenia, Visual impairment, Poor quality sleep, |
||||
EVOLOCUMAB, EZETIMIBE, |
||||
| 67 | 26945056 |
US |
2 | |
Mood altered, Dyspepsia, Pollakiuria, Injection site mass, Asthenia, Headache, Pain in extremity, Palpitations, Heart rate increased, Injection site haemorrhage, Injection site bruising, Injection site pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 68 | 26945058 |
55 | 2 | |
Loss of consciousness, Sleep apnoea syndrome, Fall, Middle insomnia, Musculoskeletal stiffness, Balance disorder, Dry throat, Asthenia, Illness, Oropharyngeal pain, Nasal congestion, Somnolence, Nocturia, Memory impairment, Disorientation, Somnambulism, Contusion, Insomnia, Fatigue, Tremor, Dyspnoea, |
||||
ARMODAFINIL, ARMODAFINIL, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, |
||||
| 69 | 26945069 |
US |
2 | |
Photophobia, Blood pressure decreased, Asthenia, Fatigue, Dizziness, Pain, Insomnia, Inappropriate schedule of product administration, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 70 | 26945073 |
US |
2 | |
Blood pressure decreased, Asthenia, |
||||
ABALOPARATIDE, |
||||
| 71 | 26945121 |
US |
2 | |
Joint swelling, Vision blurred, Hot flush, Dyspnoea, Dizziness, Palpitations, Fatigue, Asthenia, Bone pain, Diarrhoea, Abdominal distension, |
||||
ABALOPARATIDE, ADALIMUMAB, |
||||
| 72 | 26945138 |
US |
2 | |
Asthenia, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 73 | 26945180 |
CN |
28 | 2 |
Dermatitis allergic, Rash pruritic, Headache, Chest discomfort, Dyspnoea, Asthenia, Discomfort, |
||||
AMOXICILLIN, |
||||
| 74 | 26945310 |
US |
2 | |
Laboratory test abnormal, Pelvic pain, Headache, Asthenia, Back pain, Arthralgia, |
||||
ABALOPARATIDE, ABALOPARATIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, FLUTICASONE PROPIONATE, GABAPENTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SIMVASTATIN, VITAMIN C, |
||||
| 75 | 26945363 |
EU |
53 | 1 |
Malaise, Nausea, Asthenia, Somnolence, Loss of consciousness, |
||||
OBINUTUZUMAB, |
||||
| 76 | 26945432 |
US |
69 | 1 |
Fatigue, Asthenia, Asthenia, Fatigue, |
||||
| 77 | 26945634 |
US |
||
Night sweats, Splenomegaly, Hepatic enzyme increased, Asthenia, Fatigue, Pruritus, |
||||
RUXOLITINIB, ROPEGINTERFERON ALFA-2B, ROPEGINTERFERON ALFA-2B, ARIPIPRAZOLE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FENOFIBRATE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, TIRZEPATIDE, |
||||
| 78 | 26945751 |
US |
36 | 2 |
Nausea, Asthenia, Head discomfort, |
||||
| 79 | 26945799 |
US |
2 | |
Blood pressure decreased, Pain in extremity, Asthenia, |
||||
ABALOPARATIDE, LISINOPRIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 80 | 26945873 |
US |
2 | |
Food craving, Asthenia, Weight increased, Drug effect less than expected, |
||||
| 81 | 26945898 |
US |
1 | |
Weight decreased, Sleep disorder, Asthenia, |
||||
ABALOPARATIDE, DORZOLAMIDE, FAMOTIDINE, FISH OIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, LATANOPROSTENE BUNOD, |
||||
| 82 | 26945916 |
US |
83 | 2 |
Illness, Dysstasia, Asthenia, Fatigue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 83 | 26945985 |
EU |
60 | 1 |
Asthenia, Myalgia, Creatine kinase increased, Contraindicated product administered, |
||||
| 84 | 26946020 |
US |
1 | |
Hypertension, Pollakiuria, Asthenia, |
||||
SPARSENTAN, |
||||
| 85 | 26946067 |
US |
2 | |
Osteoarthritis, Somnolence, Feeling of despair, Mental impairment, Fatigue, Asthenia, Palpitations, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 86 | 26946170 |
US |
68 | 2 |
Muscular weakness, Myalgia, Headache, Asthenia, Drug ineffective, Product storage error, |
||||
ABALOPARATIDE, |
||||
| 87 | 26946192 |
US |
2 | |
Gastrooesophageal reflux disease, Weight decreased, Fatigue, Nausea, Dizziness, Asthenia, Vomiting, Headache, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 88 | 26946357 |
US |
2 | |
Illness, Tremor, Balance disorder, Fall, Dehydration, Weight decreased, Bowel movement irregularity, Diarrhoea, Vomiting, Asthenia, Malaise, |
||||
ABALOPARATIDE, |
||||
| 89 | 26946384 |
US |
2 | |
Flushing, Hyperhidrosis, Irritable bowel syndrome, Decreased appetite, Nausea, Headache, Injection site pain, Fatigue, Asthenia, Malaise, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TIRZEPATIDE, |
||||
| 90 | 26946412 |
US |
1 | |
Myalgia, Bone pain, Headache, Palpitations, Asthenia, Intentional product misuse, |
||||
ABALOPARATIDE, ABALOPARATIDE, BISOPROLOL FUMARATE, CELECOXIB, CLONAZEPAM, PANTOPRAZOLE, PREDNISONE, TAMSULOSIN HYDROCHLORIDE, RIVAROXABAN, |
||||
| 91 | 26946445 |
US |
2 | |
Myalgia, Chest discomfort, Hypoaesthesia, Feeling abnormal, Fatigue, Back pain, Asthenia, Drug hypersensitivity, |
||||
ABALOPARATIDE, APREMILAST, |
||||
| 92 | 26946470 |
US |
2 | |
Migraine, Injection site haemorrhage, Dizziness, Headache, Asthenia, Insomnia, Product dose omission in error, Product dose omission issue, Device delivery system issue, Product availability issue, Liquid product physical issue, Product contamination with body fluid, Off label use, Multiple use of single-use product, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 93 | 26946534 |
US |
1 | |
Influenza like illness, Dizziness, Asthenia, |
||||
ABALOPARATIDE, |
||||
| 94 | 26946546 |
US |
2 | |
Depression, Asthenia, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 95 | 26946644 |
US |
69 | 2 |
Liver function test abnormal, Cast application, Diarrhoea, Nausea, Asthenia, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, SACUBITRIL AND VALSARTAN, AMLODIPINE BESYLATE, BUPROPION HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 96 | 26946672 |
US |
2 | |
Pain in jaw, Palpitations, Nausea, Headache, Heart rate increased, Dizziness, Asthenia, Fatigue, Arthralgia, Blood calcium increased, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 97 | 26946684 |
US |
72 | 2 |
Somnolence, Feeling abnormal, Nausea, Asthenia, |
||||
ABALOPARATIDE, LEVOTHYROXINE SODIUM, |
||||
| 98 | 26946691 |
US |
51 | 2 |
Head discomfort, Ocular discomfort, Dysarthria, Dry mouth, Pollakiuria, Dyspnoea, Blood pressure increased, Dizziness, Headache, Asthenia, Heart rate increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, FLUTICASONE PROPIONATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, IPRATROPIUM BROMIDE AND ALBUTEROL, PREDNISONE, CYCLOSPORINE, CARBOXYMETHYLCELLULOSE SODIUM, GABAPENTIN, LIFITEGRAST, MYCOPHENOLIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, FENOFIBRATE, VALACYCLOVIR HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ALBUTEROL SULFATE, |
||||
| 99 | 26946695 |
US |
1 | |
Gait disturbance, Swelling, Pain in extremity, Asthenia, Muscle spasms, Pain, Drug ineffective, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 100 | 26946786 |
US |
2 | |
Musculoskeletal discomfort, Fatigue, Headache, Asthenia, Diarrhoea, Nausea, Drug intolerance, Product use in unapproved indication, |
||||
ABALOPARATIDE, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30